A two-sentence paragraph in a new guidance document to National Institutes of Health grant managers brings a five-year surge ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...
A two-sentence paragraph in a new guidance document to National Institutes of Health grant managers brings a five-year surge ...
News Medical on MSN18d
HPTN 094 study examines a novel way to take addiction care and HIV prevention to people who inject drugsResearchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San ...
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North ... funded by the National Institute of Allergy and Infectious Disease at the ...
It is sponsored by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID, which also funds ACTG) under award numbers UM1 AI068636, UM1 AI107716, and ...
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North ... funded by the National Institute of Allergy and Infectious Disease at the ...
Gov. Henry McMaster's pick to lead the state health department said he was abusively threatened and had his car vandalized ...
A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback